ABVC - ABVC BIOPHARMA, INC.


1.27
0.120   9.449%

Share volume: 298,448
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations: -0.13%

PREVIOUS CLOSE
CHG
CHG%

$1.15
0.12
0.10%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2023 06-30-2023 09-30-2023 12-31-2023 03-31-2024 06-30-2024 09-30-2024 03-31-2025
Fiscal Quarter Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025
Report Date 05-17-2024 08-14-2023 11-15-2023 11-14-2024 05-17-2024 08-14-2024 11-14-2024 04-30-2025
Total revenue 150.372 K 6.109 K 15.884 K 45.965 K 1.205 K 117.620 K 401.276 K 12.000 K
Cost of revenue 60.236 K 72.981 K 29.614 K 139.206 K 277.000 190.000 296.000 0.000
Gross profit 68.036 K -66.872 K -13.730 K -137.041 K 928.000 116.952 K 388.980 K 0.000
    -198.29% 79.47% -898.11% 100.68% 12,502.59% 232.60% -100.00%  
Operating expenses 1.608 M 1.901 M 1.323 M 1.599 M 900.323 K 680.852 K 339.033 K 644.232 K
Selling general and admin 1.273 M 1.387 M 1.182 M 1.527 M 831.257 K 640.451 K 301.208 K 615.371 K
Research and development 334.979 K 514.442 K 141.310 K 72.185 K 69.066 K 40.401 K 37.825 K 28.861 K
Total expenses 1.974 M 2.127 M 2.141 M -316.574 K 3.445 M 1.094 M 339.033 K 693.005 K
    7.74% 0.67% -114.79% 1,188.31% -68.26% -69.00% 104.41%  
Operating income -1.906 M -2.194 M -2.155 M -1.962 M -3.444 M -976.641 K 49.947 K -693.005 K
Ebit -1.915 M -2.209 M -2.191 M -633.797 K -3.300 M -1.151 M 97.240 K -701.417 K
Pretax income -1.897 M -2.234 M -3.369 M -3.154 M -3.981 M -1.384 M -133.917 K -944.190 K
    17.73% 50.84% -6.37% 26.20% -65.25% -90.32% 605.06%  
Income tax 0.000 81.695 K -999.000 175.310 K 0.000 -110.894 K 355.000 0.000
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                   
Net income -1.897 M -2.315 M -3.368 M -12.237 K -3.981 M -1.273 M -134.272 K -944.190 K
    -22.03% -45.48% 99.64% -32,432.64% 68.03% 89.45% -603.19%